As CMS refines the Star measure set, every remaining measure carries more importance and weak execution becomes harder to hide.
The measure changes matter beyond compliance tracking
The Star Ratings changes in the CY 2027 final notice should not be read as a simple list of adds and deletes. They reflect a continuing CMS effort to simplify and refocus the measure set. For the 2027 Star Ratings, CMS added or treated as new four measures: Colorectal Cancer Screening, Care for Older Adults – Functional Status Assessment, Concurrent Use of Opioids and Benzodiazepines, and Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults. CMS removed Care for Older Adults – Pain Assessment, Medication Reconciliation Post-Discharge, and the MTM Program Completion Rate for Comprehensive Medication Review. It also removed Statin Therapy for Patients with Cardiovascular Disease (Part C) from the Star Ratings while retaining the updated version on the 2028 display page.
These changes matter because Stars is not only a quality framework. It is a financial framework. Every meaningful adjustment to the measure mix affects how plans prioritize workflow, outreach, vendor support, and executive attention. A narrower or more targeted measure set can make remaining measures more strategically important, especially when those measures demand stronger coordination between clinical operations, pharmacy, quality teams, and member engagement functions.
What gets harder for plans from here
Many plans built their Stars machinery over time, adding teams, outreach tactics, and vendor programs in response to specific measures or annual pressure points. That often produces a portfolio of disconnected interventions rather than a coherent enterprise quality model. When CMS changes the measure set, those disconnected investments can become inefficient quickly. Programs built around retired measures lose value, while the remaining measures demand more precise execution and stronger coordination across departments.
Stars performance is increasingly an operating system problem, not a campaign problem. A plan can no longer depend on narrow interventions launched late in the year to offset broader weaknesses in member engagement, care execution, or data flow.
Why the member experience and care execution link matters
Another important takeaway is that quality performance is now more tightly tied to how the member experiences the system. Plans that separate care management from quality execution, or member outreach from provider workflow, often create friction for the very population they are trying to move. Members receive too many uncoordinated contacts. Providers face duplicative requests. Teams chase the same gaps through different systems. The result is not only inefficiency. It is weaker outcomes and less reliable measure performance.
That is why connected models are gaining traction. The strongest Stars strategies increasingly combine identification, engagement, clinical action, and documentation in one coordinated process. Instead of relying on point solutions measure by measure, plans need infrastructure and operating support that lets them respond to measure changes without rebuilding the machine every year.
Bottom line
The strategic challenge in Stars is no longer just staying current with CMS updates. It is converting those updates into repeatable operational advantage. Organizations that do that well can protect bonus revenue, strengthen rebates, and improve member outcomes at the same time.
Stars has become more strategic because the cost of weak coordination is getting higher. Plans need operating models that connect policy, workflow, engagement, and execution.